HUMAN MATURE T-CELLS THAT ARE ANERGIC INVIVO PREVAIL IN SCID MICE RECONSTITUTED WITH HUMAN PERIPHERAL-BLOOD

被引:167
作者
TARYLEHMANN, M
SAXON, A
机构
[1] Hart and Louise Lyon Laboratory, Division of Clinical Immunology/Allergy, Department of Medicine, University of California at Los Angeles School of Medicine, Los Angeles, CA
关键词
D O I
10.1084/jem.175.2.503
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In these studies we have characterized the human cells that repopulate severe combined immunodeficient (SCID) mice after injection of adult peripheral blood or cord blood (hu-PBL-SCID mice). In all organs of the chimeras, and at any time point tested, single-positive (CD4+ or CD8+) T cells that expressed the alpha/beta T cell receptor (TCR) prevailed. All T cells were CD45RO+ and the majority were also HLA-DR+. Thus, the human T cells in the chimeras exhibited the phenotype of mature, memory cells that showed signs of recent activation. Cell cycle studies revealed a mitotically active human T cell population in the murine host. However, when freshly isolated from the chimeras, the human T cells were refractory to stimulation by anti-CD3 antibody but proliferated in response to exogenous interleukin 2. Chimera-derived human T cell lines retained this state of unresponsiveness to TCR-triggered proliferation for 4-6 wk in vitro. Subsequently, the T cell lines developed responses to anti-CD3 stimulation and 9 of 11 of the lines also proliferated in response to splenic stimulator cells of SCID mice. These data demonstrate that the human T cells are in a state of reversible anergy in the murine host and that xenoreactivity might play a critical role in hu-PBL-SCID mice. Mechanisms that may determine repopulation of SCID mice with human peripheral blood mononuclear cells are discussed.
引用
收藏
页码:503 / 516
页数:14
相关论文
共 57 条
[1]   REENTRY OF T-CELLS TO THE ADULT THYMUS IS RESTRICTED TO ACTIVATED T-CELLS [J].
AGUS, DB ;
SURH, CD ;
SPRENT, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1039-1046
[2]  
AKBAR AN, 1988, J IMMUNOL, V140, P2171
[3]  
BELL EB, 1987, J IMMUNOL, V139, P1379
[4]  
BENICHOU G, 1991, IN PRESS J EXP MED
[5]  
BLUE ML, 1986, J IMMUNOL, V137, P1202
[6]  
BLUE ML, 1985, J IMMUNOL, V134, P2281
[7]   A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE [J].
BOSMA, GC ;
CUSTER, RP ;
BOSMA, MJ .
NATURE, 1983, 301 (5900) :527-530
[8]   LEU-8 TQ1 IS THE HUMAN EQUIVALENT OF THE MEL-14 LYMPH-NODE HOMING RECEPTOR [J].
CAMERINI, D ;
JAMES, SP ;
STAMENKOVIC, I ;
SEED, B .
NATURE, 1989, 342 (6245) :78-82
[9]   SMALL B-CELLS AS ANTIGEN-PRESENTING CELLS IN THE INDUCTION OF TOLERANCE TO SOLUBLE-PROTEIN ANTIGENS [J].
EYNON, EE ;
PARKER, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :131-138
[10]   A CELL-SURFACE MOLECULE INVOLVED IN ORGAN-SPECIFIC HOMING OF LYMPHOCYTES [J].
GALLATIN, WM ;
WEISSMAN, IL ;
BUTCHER, EC .
NATURE, 1983, 304 (5921) :30-34